1
Return

Clinical practice guidelines for the management of refractory postherpetic neuralgia by the Korean Pain Society

delete2026-04-01
delete1
PRE
AI
K
Kang, Hee Yong
L
Lee, Chung Hun
K
Kim, Doo-Hwan
Y
Yeon-Dong Kim
W
W KIM
J
Jae Hun Kim
H
Hyun Jung Kim
Y
Yangki Minn
K
Kyungseung Yang
J
Jinyoung Oh
Y
Y.J. Yoo
L
Lim, So Young
M
Mihn-Sook Jue
E
Eun Joo Choi
K
Kunhee Han
C
Choi, Seong-Soo
DOI:10.3344/kjp.25161delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Postherpetic neuralgia (PHN) is persistent pain that occurs after the resolution of skin lesions caused by the reactivation of the herpes zoster virus. Several first-line agents, including anticonvulsants, tricyclic antidepressants, and lidocaine patches, are used in treatment. However, systematic, evidence-based, multidisciplinary clinical practice guidelines (CPGs) addressing the use of opioids and pain interventions-such as nerve blocks-for patients with refractory PHN unresponsive to first-line agents have not yet been established. Therefore, the Korean Pain Society, in collaboration with relevant medical specialty societies, has developed de novo CPGs for the management of refractory PHN. The development process followed Cochrane's systematic literature review methodology and employed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the certainty of evidence and strength of recommendations. Key questions, identified through a survey of experts treating patients with refractory PHN, were finalized by the CPGs development panel. A literature search was conducted in four electronic databases: PubMed (MEDLINE), Embase, Cochrane Library, and KoreaMed. Studies were selected based on predefined inclusion and exclusion criteria using the population, intervention, comparison, outcomes, and study design (PICOS) framework. The resulting recommendations integrate evidence from the literature with patient and clinician preferences and values. They also take into account the quality of evidence, the balance of benefits and harms, potential barriers to implementation, and feasibility within various healthcare settings. These evidence-based multidisciplinary CPGs are expected to assist physicians in safely and effectively treating patients with refractory PHN.
Keywords:
Analgesics, Opioid
Anticonvulsants
Antidepressive Agents
Evidence-Based Medicine
Guideline
Health Planning Guidelines
Herpes Zoster
Nerve Block
Neuralgia, Postherpetic
Radiofrequency Ablation
Spinal Cord Stimulation

Journal

K
Korean Journal of Pain
IF:
3.1
Papers:
484
Citations:
1.3K

Organization

K
korea university medicine (ku medicine)
Scholars:
7.7K
Papers: 6.5K
Citations: 6
K
konkuk university
Scholars:
1.6K
Papers: 693
Citations: 0
H
hanyang university
Scholars:
2.8W
Papers: 2.7W
Citations: 36
S
Seoul National University Hospital
Scholars:
1.1W
Papers: 9.4K
Citations: 9.3K
P
pusan national university
Scholars:
2.1W
Papers: 1.8W
Citations: 20
J
jeonbuk national university
Scholars:
1.7K
Papers: 767
Citations: 0
K
korea university
Scholars:
3.7K
Papers: 1.7K
Citations: 1
K
kyungpook national university (knu)
Scholars:
1.7W
Papers: 1.7W
Citations: 14
J
jeonbuk national university hospital
Scholars:
1.1K
Papers: 890
Citations: 3
H
hallym university
Scholars:
1.1K
Papers: 452
Citations: 0
E
Ewha Womans University
Scholars:
1.1W
Papers: 1.1W
Citations: 1.2W
K
Konkuk University Medical Center
Scholars:
2.5K
Papers: 2.0K
Citations: 817
S
seoul national university (snu)
Scholars:
7.1W
Papers: 6.6W
Citations: 86
K
Kyung Hee University
Scholars:
2.5K
Papers: 989
Citations: 639
Cited Papers

Cited Papers

Citing Papers

Citing Papers